
Nancy Bitar
Examiner (ID: 18935, Phone: (571)270-1041 , Office: P/2669 )
| Most Active Art Unit | 2664 |
| Art Unit(s) | 2624, 2669, 2664 |
| Total Applications | 1257 |
| Issued Applications | 1017 |
| Pending Applications | 63 |
| Abandoned Applications | 197 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9401454
[patent_doc_number] => 08691506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-08
[patent_title] => 'Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds'
[patent_app_type] => utility
[patent_app_number] => 11/911222
[patent_app_country] => US
[patent_app_date] => 2006-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18823
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 227
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11911222
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/911222 | Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds | Apr 12, 2006 | Issued |
Array
(
[id] => 5852023
[patent_doc_number] => 20060235214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Identification of cancer genes using a high-throughput forward genetic screening method'
[patent_app_type] => utility
[patent_app_number] => 11/400132
[patent_app_country] => US
[patent_app_date] => 2006-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2108
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20060235214.pdf
[firstpage_image] =>[orig_patent_app_number] => 11400132
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/400132 | Identification of cancer genes using a high-throughput forward genetic screening method | Apr 6, 2006 | Abandoned |
Array
(
[id] => 11231265
[patent_doc_number] => 09458487
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-04
[patent_title] => 'Expression of mammalian proteins in pseudomonas fluorescens'
[patent_app_type] => utility
[patent_app_number] => 11/400840
[patent_app_country] => US
[patent_app_date] => 2006-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 25411
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11400840
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/400840 | Expression of mammalian proteins in pseudomonas fluorescens | Apr 6, 2006 | Issued |
Array
(
[id] => 5625304
[patent_doc_number] => 20060263809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Method for sensitive measure of low level apoptosis in cells'
[patent_app_type] => utility
[patent_app_number] => 11/399120
[patent_app_country] => US
[patent_app_date] => 2006-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10440
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20060263809.pdf
[firstpage_image] =>[orig_patent_app_number] => 11399120
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/399120 | Method for sensitive measure of low level apoptosis in cells | Apr 4, 2006 | Abandoned |
Array
(
[id] => 9703665
[patent_doc_number] => 08828726
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-09
[patent_title] => 'Circular nucleic acid vectors, and methods for making and using the same'
[patent_app_type] => utility
[patent_app_number] => 11/398490
[patent_app_country] => US
[patent_app_date] => 2006-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 12
[patent_no_of_words] => 11299
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11398490
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/398490 | Circular nucleic acid vectors, and methods for making and using the same | Apr 3, 2006 | Issued |
Array
(
[id] => 8591680
[patent_doc_number] => 08349555
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-08
[patent_title] => 'Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures'
[patent_app_type] => utility
[patent_app_number] => 11/908775
[patent_app_country] => US
[patent_app_date] => 2006-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 24
[patent_no_of_words] => 23218
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11908775
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908775 | Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures | Mar 15, 2006 | Issued |
Array
(
[id] => 4921934
[patent_doc_number] => 20080070249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Novel Activating Agent of Glucose Uptake and a Screening Method Therefor'
[patent_app_type] => utility
[patent_app_number] => 11/663194
[patent_app_country] => US
[patent_app_date] => 2006-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8199
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20080070249.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663194
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663194 | Novel Activating Agent of Glucose Uptake and a Screening Method Therefor | Mar 13, 2006 | Abandoned |
Array
(
[id] => 4893425
[patent_doc_number] => 20080102523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'Expression Vector for Animal Cell Comprising at Least One Copy of Mar Dna Sequences at the 3\'Terminal of Transcription Termination Region of a Gene and Method for the Expression of Foreign Gene Using the Vector'
[patent_app_type] => utility
[patent_app_number] => 11/817756
[patent_app_country] => US
[patent_app_date] => 2006-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7107
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20080102523.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817756
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817756 | Expression vector for animal cell comprising at least one copy of MAR DNA sequences at the 3′ terminal of transcription termination region of a gene and method for the expression of foreign gene using the vector | Mar 3, 2006 | Issued |
Array
(
[id] => 5608054
[patent_doc_number] => 20060269570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Recombinant double-stranded RNA phage, and use of the same'
[patent_app_type] => utility
[patent_app_number] => 11/361007
[patent_app_country] => US
[patent_app_date] => 2006-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17456
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20060269570.pdf
[firstpage_image] =>[orig_patent_app_number] => 11361007
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/361007 | Recombinant double-stranded RNA phage, and use of the same | Feb 23, 2006 | Issued |
Array
(
[id] => 5732250
[patent_doc_number] => 20060257367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Tumour-cell specific gene expression and its use in cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 11/352053
[patent_app_country] => US
[patent_app_date] => 2006-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10289
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257367.pdf
[firstpage_image] =>[orig_patent_app_number] => 11352053
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/352053 | Tumour-cell specific gene expression and its use in cancer therapy | Feb 9, 2006 | Abandoned |
Array
(
[id] => 5874154
[patent_doc_number] => 20060166251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Use of sFRPs as markers of BMP activity'
[patent_app_type] => utility
[patent_app_number] => 11/339549
[patent_app_country] => US
[patent_app_date] => 2006-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8192
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166251.pdf
[firstpage_image] =>[orig_patent_app_number] => 11339549
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/339549 | Use of sFRPs as markers of BMP activity | Jan 25, 2006 | Abandoned |
Array
(
[id] => 5705182
[patent_doc_number] => 20060194230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Genetic markers associated with benign prostatic hyperplasia'
[patent_app_type] => utility
[patent_app_number] => 11/339733
[patent_app_country] => US
[patent_app_date] => 2006-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 24936
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194230.pdf
[firstpage_image] =>[orig_patent_app_number] => 11339733
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/339733 | Genetic markers associated with benign prostatic hyperplasia | Jan 24, 2006 | Abandoned |
Array
(
[id] => 5062956
[patent_doc_number] => 20070224596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-27
[patent_title] => 'Compositions and methods for the modifying hypoxia induced gene regulation'
[patent_app_type] => utility
[patent_app_number] => 11/247103
[patent_app_country] => US
[patent_app_date] => 2006-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 79334
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20070224596.pdf
[firstpage_image] =>[orig_patent_app_number] => 11247103
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/247103 | Compositions and methods for the modifying hypoxia induced gene regulation | Jan 19, 2006 | Abandoned |
Array
(
[id] => 5753480
[patent_doc_number] => 20060222629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Compositions and methods for delivery of genetic material'
[patent_app_type] => utility
[patent_app_number] => 11/317548
[patent_app_country] => US
[patent_app_date] => 2005-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 30431
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20060222629.pdf
[firstpage_image] =>[orig_patent_app_number] => 11317548
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/317548 | Compositions and methods for delivery of genetic material | Dec 22, 2005 | Issued |
Array
(
[id] => 8446034
[patent_doc_number] => 08288085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-16
[patent_title] => 'Method of separating pancreatic islet'
[patent_app_type] => utility
[patent_app_number] => 11/793679
[patent_app_country] => US
[patent_app_date] => 2005-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 12516
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11793679
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/793679 | Method of separating pancreatic islet | Dec 21, 2005 | Issued |
Array
(
[id] => 9970959
[patent_doc_number] => 09017965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-28
[patent_title] => 'Hybrid 3′ untranslated regions suitable for efficient protein expression in mammalian cells'
[patent_app_type] => utility
[patent_app_number] => 12/097169
[patent_app_country] => US
[patent_app_date] => 2005-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6992
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12097169
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/097169 | Hybrid 3′ untranslated regions suitable for efficient protein expression in mammalian cells | Dec 11, 2005 | Issued |
Array
(
[id] => 5649046
[patent_doc_number] => 20060134781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Three-dimensional cell culture system'
[patent_app_type] => utility
[patent_app_number] => 11/296802
[patent_app_country] => US
[patent_app_date] => 2005-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12094
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134781.pdf
[firstpage_image] =>[orig_patent_app_number] => 11296802
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/296802 | Three-dimensional cell culture system | Dec 6, 2005 | Abandoned |
Array
(
[id] => 5661460
[patent_doc_number] => 20060252056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Markers for responsiveness to an erbB receptor tyrosine kinase inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/290173
[patent_app_country] => US
[patent_app_date] => 2005-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 26061
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252056.pdf
[firstpage_image] =>[orig_patent_app_number] => 11290173
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/290173 | Markers for responsiveness to an erbB receptor tyrosine kinase inhibitor | Nov 29, 2005 | Abandoned |
Array
(
[id] => 5815268
[patent_doc_number] => 20060084798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'cDNAs and proteins involved in hypoxia, circadian and orphan signal transduction pathways, and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/288720
[patent_app_country] => US
[patent_app_date] => 2005-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22128
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084798.pdf
[firstpage_image] =>[orig_patent_app_number] => 11288720
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/288720 | cDNAs and proteins involved in hypoxia, circadian and orphan signal transduction pathways, and methods of use | Nov 28, 2005 | Issued |
Array
(
[id] => 5655769
[patent_doc_number] => 20060141504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Molecular technologies for improved risk classification and therapy for acute lymphoblastic leukemia in children and adults'
[patent_app_type] => utility
[patent_app_number] => 11/285976
[patent_app_country] => US
[patent_app_date] => 2005-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17979
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20060141504.pdf
[firstpage_image] =>[orig_patent_app_number] => 11285976
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/285976 | Molecular technologies for improved risk classification and therapy for acute lymphoblastic leukemia in children and adults | Nov 22, 2005 | Abandoned |